|
|
Volumn 2, Issue , 1996, Pages 165-173
|
|
DNA damage checkpoints: implications for cancer therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANIMAL;
APOPTOSIS;
CELL CYCLE;
CELL CYCLE G1 PHASE;
CELL CYCLE G2 PHASE;
CELL CYCLE S PHASE;
DNA DAMAGE;
GENETICS;
HUMAN;
NEOPLASM;
PATHOLOGY;
REVIEW;
TUMOR SUPPRESSOR GENE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL CYCLE;
DNA DAMAGE;
G1 PHASE;
G2 PHASE;
GENES, P53;
HUMANS;
NEOPLASMS;
S PHASE;
|
|
EID: 0030310066
PISSN: 10872957
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-4615-5873-6_16 Document Type: Review |
|
Times cited : (49)
|
|
References (93)
|
